ArticleAmerican journal of translational research2024

Clinical effect of Almonertinib in treating epidermal growth factor receptor mutation-positive residual ground-glass opacities after stage I lung cancer resection.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.